Fonar Corp (FONR)
16.20
+0.30
(+1.89%)
USD |
NASDAQ |
Oct 04, 16:00
16.30
+0.10
(+0.62%)
After-Hours: 20:00
Fonar Research and Development Expense (Annual): 1.736M for June 30, 2024
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 1.736M |
June 30, 2023 | 1.568M |
June 30, 2022 | 1.494M |
June 30, 2021 | 1.636M |
June 30, 2020 | 2.025M |
June 30, 2019 | 1.812M |
June 30, 2018 | 1.756M |
June 30, 2017 | 1.481M |
June 30, 2016 | 1.632M |
June 30, 2015 | 1.812M |
June 30, 2014 | 1.761M |
June 30, 2013 | 1.439M |
June 30, 2012 | 1.243M |
June 30, 2011 | 1.44M |
June 30, 2010 | 2.458M |
June 30, 2009 | 3.594M |
Date | Value |
---|---|
June 30, 2008 | 5.007M |
June 30, 2007 | 5.692M |
June 30, 2006 | 6.868M |
June 30, 2005 | 6.007M |
June 30, 2004 | 5.491M |
June 30, 2003 | 5.164M |
June 30, 2002 | 5.10M |
June 30, 2001 | 5.866M |
June 30, 2000 | 5.532M |
June 30, 1999 | 6.60M |
June 30, 1998 | 6.50M |
June 30, 1997 | 3.90M |
June 30, 1996 | 3.60M |
June 30, 1995 | 3.40M |
June 30, 1994 | 2.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.494M
Minimum
2022
2.025M
Maximum
2020
1.692M
Average
1.636M
Median
2021
Research and Development Expense (Annual) Benchmarks
XWELL Inc | -- |
ProPhase Labs Inc | 1.418M |
Applied DNA Sciences Inc | 3.735M |
Veracyte Inc | 57.30M |
OncoCyte Corp | 9.294M |